These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11585006)

  • 1. Ziprasidone: a new atypical antipsychotic.
    Keck PE; McElroy SL; Arnold LM
    Expert Opin Pharmacother; 2001 Jun; 2(6):1033-42. PubMed ID: 11585006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
    Stimmel GL; Gutierrez MA; Lee V
    Clin Ther; 2002 Jan; 24(1):21-37. PubMed ID: 11833834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone, a new atypical antipsychotic drug.
    Carnahan RM; Lund BC; Perry PJ
    Pharmacotherapy; 2001 Jun; 21(6):717-30. PubMed ID: 11401184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of atypical antipsychotics in mood disorders.
    Weizman R; Weizman A
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpromazine equivalent doses for the newer atypical antipsychotics.
    Woods SW
    J Clin Psychiatry; 2003 Jun; 64(6):663-7. PubMed ID: 12823080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
    Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
    World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Rosenheck RA; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK;
    Am J Psychiatry; 2006 Apr; 163(4):611-22. PubMed ID: 16585435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
    Raggi MA; Mandrioli R; Sabbioni C; Pucci V
    Curr Med Chem; 2004 Feb; 11(3):279-96. PubMed ID: 14965232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
    McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK;
    Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new generation of antipsychotic drugs.
    Tamminga CA; Lahti AC
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():73-6. PubMed ID: 8803664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM; Shayegan DK
    J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and new antipsychotics in schizophrenia. Are patients better off?
    Awad AG; Voruganti LN
    Int J Soc Psychiatry; 1999; 45(4):268-75. PubMed ID: 10689610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia, VI: Treatments.
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.